IL-10 induces TGF-β secretion, TGF-β receptor II upregulation, and IgA secretion in B cells.


Journal

European cytokine network
ISSN: 1952-4005
Titre abrégé: Eur Cytokine Netw
Pays: France
ID NLM: 9100879

Informations de publication

Date de publication:
01 09 2019
Historique:
entrez: 21 1 2020
pubmed: 21 1 2020
medline: 19 5 2020
Statut: ppublish

Résumé

Interleukin-10 (IL-10) is a pleiotropic cytokine, which has both regulatory and stimulatory effects on different immune cell types. Different studies have reported the importance of IL-10 and Transforming growth factor-beta (TGF-β) in the regulation of B cell class switching the production of immunoglobulin A (IgA); however, the underlying mechanisms remain to be fully elucidated. The objective of this study was to investigate the TGF-β response during B stimulation of human B cells by IL-10. Pan B cells of healthy donors were negatively purified by a magnetic cell separation technique. B cells were cultured with multimeric CD40 ligand (mCD40L) and IL-10 for two and seven days. After harvesting in specific days, TGF-β receptor II and surface IgA expression was determined by flow cytometry, while IgA and TGF-β secretion was assessed by enzyme-linked immunosorbent assay. B cells endogenously expressed TGF-β receptor II and after 48 hours cultivation with mCD40L or mCD40L plus IL-10, both the expression of this receptor and the production of TGF-β were significantly increased. Notably, TGF-β levels following stimulation with mCD40L and IL-10 were higher than those produced by B cells stimulated with mCD40L alone. Furthermore, at day 7 and following IL-10 stimulation, there was a significant rise in the amount of IgA secretion by class-switched plasma cells, which was higher than stimulation with mCD40L alone. Our findings suggest that IL-10 can modulate TGF-β production and TGF-β receptor expression in mCD40-activated human B lymphocytes.

Identifiants

pubmed: 31957700
pii: ecn.2019.0434
doi: 10.1684/ecn.2019.0434
doi:

Substances chimiques

CD40 Antigens 0
IL10 protein, human 0
Immunoglobulin A 0
Receptors, Transforming Growth Factor beta 0
Transforming Growth Factor beta 0
Interleukin-10 130068-27-8
CD40 Ligand 147205-72-9

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

107-113

Auteurs

Yasser Bagheri (Y)

Iran University of Medical Sciences, Institute of Immunology and Infectious Diseases, Immunology Research Center (IRC), Tehran, Iran.
Tarbiat Modares University, Faculty of Medical Sciences, Department of Immunology, Tehran, Iran.

Fateme Babaha (F)

Iran University of Medical Sciences, Institute of Immunology and Infectious Diseases, Immunology Research Center (IRC), Tehran, Iran.

Reza Falak (R)

Tarbiat Modares University, Faculty of Medical Sciences, Department of Immunology, Tehran, Iran.

Reza Yazdani (R)

Tehran University of Medical Sciences, Pediatrics Center of Excellence, Children's Medical Center, Research Center for Immunodeficiencies, Tehran, Iran.

Gholamreza Azizi (G)

Alborz University of Medical Sciences, Non-Communicable Diseases Research Center, Karaj, Iran.

Maryam Sadri (M)

Iran University of Medical Sciences, School of Medicine, Department of Immunology, Tehran, Iran.

Hassan Abolhassani (H)

Tehran University of Medical Sciences, Pediatrics Center of Excellence, Children's Medical Center, Research Center for Immunodeficiencies, Tehran, Iran, Karolinska Institute at Karolinska University Hospital Huddinge, Department of Laboratory Medicine, Division of Clinical Immunology, Stockholm, Sweden.

Mehdi Shekarabi (M)

Tarbiat Modares University, Faculty of Medical Sciences, Department of Immunology, Tehran, Iran.

Asghar Aghamohammadi (A)

Tehran University of Medical Sciences, Pediatrics Center of Excellence, Children's Medical Center, Research Center for Immunodeficiencies, Tehran, Iran.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH